Class Action Legal News articles include legal news and lawsuit information about lawsuits filed, settlements reached and verdicts rendered in class action cases dealing with personal injury, defective products, bad drugs and other consumer law related news issues. Many of these articles include interviews from top legal professionals with guidance on legal recourse options from losses resulting from bad drugs, medical malpractice, investment fraud, personal injury, defective products and negligent employers.
Bejing, China: As Bejing cracks down on Chinese manufacturers exporting defective products to the US, China has reported a suicide in the wake of the recent Mattel toy recall.
Phoenix, AZ: Officials from the Food and Drug Administration say that some of the cans involved in the recent Castleberry recall have begun to burst due to gasses created by the bacteria that cause botulism disease. The Castleberry Food Co. recalled more than 90 of the canned food products it manufactures in July after they were linked to an outbreak of botulism food poisoning.
Seattle, WA: What do baby bottles, flame retardants and some resins have in common? They all contain Bisphenol A (BPA), an industrial chemical used to make polycarbonate plastic resins, epoxy resins, and other products. Because this kind of plastic is lightweight and heat resistant (among other attributes) it is used in a wide variety of products including reusable food and drink containers and baby bottles.
Washington, DC: According to US Renal Data System and the Medicare Payment Advisory Commission, Medicare spends about $64,000 annually for each person on hemodialysis for all medical services, and the anemia drugs Procrit, Epogen and Aranesp are the single largest drug expense for Medicare.
Washington, DC: On July 20, 2007, the Centers for Medicare & Medicaid Services issued new reimbursement rules that limit the use and dosage for a class of anemia drugs known as erythropoiesis stimulating agents (ESA's), in large part prompted by findings that the medications were being over-prescribed for profit under the current billing rules.
Natick, MA: The Guidant division of Boston Scientific may have dodged a more expensive bullet by settling claims stemming from the recall of Guidant Implantable Cardioverter Defibrillators (ICD), even though it cost the company $195 million to do it.
Vancouver, BC: A recent increase of laboratory isolations of acanthamoeba keratitis (AK) has been observed in BC, according to the Vancouver Sun. Hundreds of cases of AK, a potentially blinding eye condition, have been reported across North America, leading to the recall of AMO Complete All-In-One Contact Lens Care Solution in Canada.